Prior to 2004, NMO was often regarded as a specific subtype of multiple sclerosis (MS), but the recent discovery of AQP4 and NMO-IgG supports considering it as an independent disease (3–5). This evidence concerns the gene AQP4 and neuromyelitis optica.